http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Da-hye Ju ),( Sang Jin Ha ),( Hyeyeon Lee ) 대한산부인과학회 2019 대한산부인과학회 학술대회 Vol.105 No.-
Objective: The aim of the current study was to examine the prevalence and time interval of metabolic syndrome development among women with hypertensive disorders of pregnancy compared to those of women with a normal delivery using big data analysis of a customized database using a National Health Insurance System data registry and to compare the prevalence of MS components between the HDP group and the normal delivery group. Methods: Data from 2002 to 2012 from the National Health Insurance Research Database in Korea was used to compare women diagnosed with HDP with those with a normal singleton pregnancy. The women who had medical checkups between 2009 and 2016 were assessed for MS. Using the customized DB, we conducted a trajectory analysis of MS development in our cohort. Results: Between 2002 and 2012, there were a total of 4723541 deliveries. Among the women who were analyzed, a total of 305919 underwent a medical examination from 2009 to 2016. MS was diagnosed in 47459 cases (22%). MS was found in 20.3% of the women in the normal group and 37.1% of the women in the HDP group. The time to MS development in women who had experienced pregnancy complicated by HDP was significantly shorter than that of women who did not experience HDP (6.6 ± 3.4 years vs 8.2 ± 3.4 years, p<0.0001). Women with a history of HDP had significantly increased odds of developing MS (OR 1.23; 95% CI, 1.12-1.35) and elevated systolic blood pressure strongly contributed the increased odds of developing MS in the HDP group (OR 1.644; 95% CI, 1.610-1.678). Conclusion: Our findings suggest that HDP increases the risk of MS development in later life and that MS develops in a shorter period of time in women with HDP than in those with a normal delivery. Women with HDP should be intensively checked for the components of MS.
재발성 또는 지속성 상피성 난소암에서의 Docetaxel 요법의 효용성 및 독성
주다혜 ( Da Hye Ju ),김용만 ( Yong Man Kim ),김민균 ( Min Gyun Kim ),김유진 ( Eu Gene Kim ),김대연 ( Dae Yeon Kim ),서대식 ( Dae Sik Seo ),김종혁 ( Jong Hyeok Kim ),김영탁 ( Young Tak Kim ),남주현 ( Joo Hyun Nam ) 대한산부인과학회 2007 Obstetrics & Gynecology Science Vol.50 No.11
Objective: The aim of this study is to determine the efficacy and toxicity of docetaxel in patients with recurrent or persistent epithelial ovarian cancer, previously treated with paclitaxel and platinum combination chemotherapy. Methods: Forty patients with recurrent or persistent epithelial ovarian cancer, had been treated with docetaxel combination chemotherapy at Asan Medical Center from May 1989 to December 2006. They received docetaxel (75 mg/m2) only or docetaxel (75 mg/m2) and platinum (carboplatin AUC5 or cisplatin 75 mg/m2) on day 1. The administration was repeated every 3 or 4 weeks. The response of patients was evaluated with CA-125 response criteria and RECIST criteria. The toxicities were defined according to the NCI common toxicity criteria. Results: Twenty patients had been evaluated by RECIST criteria and twenty patients had been evaluated by CA-125 response criteria. The overall response rate was 35% (14/40). Eleven patients were belonged to complete response (CR), and three patients were belonged to partial response (PR). The mean response duration (RD) was 11.29 months (4 to 20.7 months) and the mean time to progression (TTP) was 6.91 months (1 to 23 months). The response rate in the platinum-sensitive patients was 38.7% but in the platinum-resistant patients was 22.2%. The platinum-sensitive patients showed more favorable response rate, but that was not significant statistically. Heavily treated group, more than three prior regimens were used, had poor outcome. The common toxicities were alopecia and gastrointestinal toxicities (anorexia and nausea). Bone marrow suppression was the most serious drug toxicity, however, it was tolerable. Conclusion: The docetaxel is a considerable 2nd line chemotherapy with acceptable efficacy and toxicity in patients with recurrent or persistent epithelial ovarian cancer previously treated with paclitaxel and platinum combination chemotherapy.
The anti-obesity effect of GRHE on adipogenesis and lipogenesis in 3T3-L1 Cell
Da-Hye Choi,Joon-Hee Han,Min Hong,Hyun-Ju Lee,Sun-Yeop Lee,Tae-Hyung Kwon,Soo-Ung Lee 한국식품영양과학회 2021 한국식품영양과학회 학술대회발표집 Vol.2021 No.10
The GRHE sample has been widely used as nutritious nut in Korea. Therefore, we investigated to elucidate the anti-oxidant and anti-obesity effects of the 20% ethanol extract of GRHE. The GRHE showed markedly strong DPPH and ABTS radical scavenging activities at various concentration. Total lipid accumulation and triglycerides (TGs) decreased in the GRHE-treated 3T3-L1 cells without toxicity. In addition, we identified the inhibited expression of anti-obesity marker genes at the mRNA and protein level. The GRHE effectively suppressed the expression of adipogenesis (PPARγ, and SREBP1c) and lipogenesis (FAS) related genes. These results indicate that the GRHE could have potential application in the prevention and treatment of obesity-associated disorders.
Aryl diester들에 존재하는 methoxycarbonylmethylester group의 상대적 반응성에 관한 연구
정혜진, 채수연, 표수진, 김다미,이유빈, 최의진, 김진주, 남궁성건 서울여자대학교 자연과학연구소 2016 자연과학연구논문집 Vol.28 No.-
The aryl diesters (1-3) and (8A) were prepared to investigate efficiency of methoxycarbonylmethyl (MCM) group as both protecting group specific for carboxylic acids and activating group for several functional group transformation reactions. MCM ester was very stable under strongly acidic condition and easily deprotected to its acid under mild basic condition. MCM ester of diclofenac (5B) proved to be one of activated esters through base-promoted cyclization reaction. MCM ester was also effective for transesterification reaction and reduction under the presented reaction conditions. Finally, MCM ester was not reactive to pri- and sec-aliphatic amines.
P-10 : Role of Polypyrimide Tract-Binding Protein in HCV RNA Replication
( Hye Soo Son ),( Bo Kyoung Kim ),( Da Hui Ahn ),( Eun Ju Baek ),( Jeong Hoon Park ),( Kyung Soo Chang ) 대한임상병리사협회 2008 임상미생물검사학회 발표자료집 Vol.2008 No.-
Background : Translation initiation of the hepatitis C virus (HCV) is regulated by an internal ribosome entry site (IRES) which requires polypyrimidine tractbinding protein (PTB), which binds to the 5``-untranslated region (UTR) and the 3``-UTR and the end of the core coding region of HCV RNA, for its function. Aims of this Study are to determine the role of PTB in HCV replication. Methods : siRNA technology was used to specifically knockdown the PTB expression in the cell. We determined whether down-expression of PTB affects the EMCV IRES-mediated translation, and examined whether interferon (IFN) down-regulates PTB expression. Results : In this study, we discovered that the level of PTB expression was efficiently decreased by PTB-specific siRNA. PTB knockdown expression by siRNA significantly reduced the efficiency of cell colony formation induced by HCV RNA replication. PTB siRNA resulted in a significant reduction of PTB expression and therein HCV RNA replication in a subgenomic HCV replicon-bearing Huh7 cell line, suggesting that PTB is required for efficient HCV replication in vivo. Result: PTB siRNA does not significantly affect the efficiency of the EMCV IRES-mediated translation. IFN-α resulted in an inhibition of PTB expression, suggesting a potential mechanism by which IFN inhibits HCV replication. Discussion : PTB siRNA efficiently knockdowns the level of PTB expression and subsequently resulted in a significant reduction of HCV RNA replication, indicating that PTB is required for efficient HCV RNA replication in vivo. It appears that IFN-α inhibits PTB expression, suggesting that inhibition of HCV replication by IFN might be due to suppression of cellular proteins that are required for HCV RNA replication.